INJ consolidates within $4.40–$5.55 recent range amid persistent long-term resistance: weekly forecast
Injective (INJ) is currently trading at $4.62, marking a weekly gain of $0.34 or 7.85%. The asset sits above its MA-20 ($3.64), but remains well below both the MA-50 ($7.75) and MA-200 ($12.99), highlighting a short-term recovery amid persistent long-term bearish pressure.
Highlights
- INJ price action shows short-term buyer dominance but fails to sustain gains above previous weekly highs.
- Key technical indicators present conflicting signals, with momentum bearish but short-term oscillators indicating overbought conditions.
- INJ is expected to consolidate within a $4.40–$5.55 range, with a higher probability of sideways or downward price movement.
Mixed technical outlook as overbought signals clash with persistent selling
Weekly technical analysis on INJ highlights diverging signals. The price holds above MA-20 acting as dynamic support, while the MA-50 and MA-200 overhead signal unresolved longer-term resistance. Support for the week is located near $4.40, with resistance at $5.55. The weekly RSI remains in the sell zone, and although Stochastic RSI and CCI are overbought, momentum readings from MACD and ADX point to ongoing selling pressure. Bull/Bear Power indicators also show overbought conditions, while weekly volatility at 37.61% signals significant price swings.
Sideways bias expected as limited upside probability tempers breakout hopes
For the next 7 days, INJ is expected to trade between $4.40 and $5.55, likely consolidating within this range after recent volatility. A bullish scenario would require a sustained breakout above $5.55, potentially triggering renewed upside momentum. However, with none of the four key weekly indicators registering Buy or Strong Buy, an upward move carries less than a 20% probability. The base case anticipates sideways movement, while a break below $4.40 could expose INJ to renewed downside pressure towards longer-term support levels.
Earlier, analysts noted that Injective maintained a broadly bullish short-term structure but faced mixed momentum signals amid heightened volatility. The current setup reinforces those cautionary signals, with a potential consolidation phase ahead and increased significance on the $4.40 support level as a trigger for renewed downside risk.
Latest Injective News
- Forex
- Crypto